Skip to content

Clinical trials

Phase 3 COVID-19 trials in Pakistan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 3 Country / region: Pakistan Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
202013
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Atea Pharmaceuticals, Inc.1
Ayub Teaching Hospital1
CanSino Biologics Inc.1
Fatima Memorial Hospital1
Liaquat University of Medical & Health Sciences1
Livzon Pharmaceutical Group Inc.1
London School of Hygiene and Tropical Medicine1
NICHD Global Network for Women's and Children's Health1
Population Health Research Institute1
Prof. Dr. Fridoon Jawad Ahmad1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1917
Coronavirus Infections3
Pneumonia2
Community-Acquired Pneumonia1
Disease Progression1
Dyspnea1
Inflammation1
Influenza, Human1
Lung Diseases1
Maternal Death1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.